Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

3D Printing

Event: HINJ and Rutgers Biomedical Engineering Medical Device Development Center Kick Off Forum Series with ‘Innovations in 3-D Printing’ on September 19

Piscataway, NJ, September 18, 2017 — Please join the Rutgers Biomedical Engineering Medical Device Development Center and the HealthCare Institute of New Jersey (HINJ) for “Innovations in 3-D Printing: The Latest Technology in Industry” on Tuesday, September 19 at Rutgers’ Busch Campus in Piscataway, NJ.

The free event will be the first in Rutgers and HINJ’s Fall series of educational panels and seminars that focus on the medical device industry.

Attendees will learn the latest about 3-D printing technology and its innovative uses in pre-surgical planning, training and medical device industry applications. Continue reading

3-D Printing Advances Make the Technology More Useful for Surgery, Implants, Creating Drugs

New York, NY, September 15, 2017 — Aili McConnon reports in The Wall Street Journal that Mayo Clinic is part of a web of organizations racing to find ways to use 3-D printing to improve health care.

Some research institutions, including the Mayo Clinic, have set up on-site printing labs in partnership with such makers of 3-D printers as Stratasys, 3D Systems and Formlabs.

McConnon reports that General Electric Co. and Johnson & Johnson are diving in, too, with GE focused on 3-D printers and translating images from various sources into 3-D objects, and J&J focused on developing a range of materials that can be used as “ink” to print customized objects. Continue reading

Rutgers RWJ’s Dr. Gaurav Gupta Puts a 3D-Printed Skull Bone into Patient’s Head

Dr. Gaurav Gupta and patient Christopher Cahill

New Brunswick, NJ, August 22, 2017 — MaryLynn Schiavi reports in USA Today that a decade ago, the idea of printing parts of the human body through 3D printing was still in the realm of science fiction.

But on March 28, Dr. Gaurav Gupta, assistant professor of neurosurgery at Rutgers Robert Wood Johnson Medical School, successfully inserted a 3D-printed skull implant into patient Christopher Cahill, of New Brunswick, during a four-hour surgery.

Cahill suffered an injury to the frontal lobe in early 2017 that resulted in life-threatening brain swelling.  After emergency surgery relieved the swelling, Gupta determined that Cahill’s skull was unusable because of an infection in the skull. Continue reading

FDA Touts 3D Printing’s Potential in Personalized Medicine

3D Printing MedicalWashington, DC, July 15, 2016 — Christine Ayala reports in The Hill that the Food and Drug Administration (FDA) touted the potential of 3D-printed medical devices and drugs Thursday, releasing regulatory science research on devices already cleared and approved by the agency.

The FDA issued draft guidance on 3D-printed devices in May, which is currently open for comment until Aug. 8.

James Coburn, the principal investigator for the FDA’s Center for Devices and Radiological Health, highlighted the potential for advancements in personalized medicine through 3D printing, also called additive manufacturing. Continue reading

How a 3D Printer at Rowan University Could Mean a Breakthrough for Joint-Replacement Surgery

Rowan University logoGlassboro, NJ, July 7, 2016 — Caitlyn Stulpin reports in The Star-Ledger/NJ.com that, in a lab located in the engineering building of Rowan University, a team of researchers gather around a 3D printer.  The team watches as the printer finishes up its latest job, leaving a knob of plastic behind.

But this isn’t just any piece of plastic.  It’s an FDA-approved piece of plastic that could one day be a knee replacement capable of releasing medicine to fight off infections in someone’s leg.

The driving force behind this project are the thousands of patients who rely on medical technology to replace their aging joints, but succumb to additional surgery to treat post-op infections. Continue reading

Cellular Architecture: Rutgers-Camden Students Use 3D Bioprinter to Create Building Blocks for Tissue Generation

Rutgers CamdenCamden, NJ, June 19, 2016 — Ed Moorhouse reports on Rutgers-Camden New Now advances in technology have made it possible to produce bone, muscle, and even organs using a 3D bioprinter, which allows scientists to generate tissue in a laboratory environment.

But before that can be done, cellular building blocks have to be created to lay the foundation for the new tissue, and students at Rutgers University–Camden are playing the role of architect.

“We’re interested in using carbohydrate and protein materials such as cellulose and silk to create scaffolding on which organs can grow,” says Ashley Lewis, a junior at Rutgers–Camden who is majoring in both biology and philosophy. “You can’t just randomly take cells and make an organ. You have to have some sort of infrastructure so that they will grow, and it’s a nuanced process.” Continue reading

The Dream of 3D-Printed Organs Depends on Keeping Cells Alive—A New Advance Could Help

STATBoston, MA, February 17, 2016 ― Rebecca Robbins reports on STAT that there is plenty of excitement around the promise of machines that can spit out living cells patterned to create three-dimensional biological structures.

But the dream of functional 3-D-printed tissue and organs has long been stymied by a stubborn central challenge: how to get blood to flow to keep the cells alive.

Now, Robbins reports, a team of researchers at the Wake Forest School of Medicine in North Carolina has made the latest contribution to solving the puzzle, though their findings are still a long way away from helping patients. Continue reading